Colorectal Cancer Center

Through close multidisciplinary treatment among the medical personnel from the Division of Colorectal Surgery, Division of Hematology/Medical Oncology, Division of Gastroenterology, Department of Radiology, Department of Radiation Oncology, and Department of Pathology, who boast a wealth of clinical experience, professional knowledge, and technical competence, the Colorectal Cancer Center promotes the maximization of the therapeutic effect of colorectal cancer patients.

In addition, it leads clinical tests at home and abroad and stands at the forefront of basic research, thus playing a role as a global leader of the examination and treatment of and research on colorectal cancer.

The center has performed anus-preservation even in the case of central and lower rectal cancer, which in the past necessitated anus removal, and exhibited results similar to those of past surgical methods, thus allowing patients to maintain the defecation function and raising their quality of life.

When performing surgeries on rectal cancer removed from the anus by 3-5 cm, the anus-preservation rate is 86.5%, which surpasses 57% of the Memorial Sloan-Kettering Cancer Center (MSKCC), a world-famous cancer hospital in the United States.

In addition, the center has led the minimally invasive surgery of colorectal cancer by successfully performing laparoscopic colorectal cancer surgery for the first time in Korea and demonstrated the excellence of laparoscopic surgery through a multi-center, randomized, prospective, comparative clinical research.

Since the establishment in 1991 of the Korean Hereditary Colorectal Cancer Registry, it has led research on hereditary colorectal cancer worldwide by conducting professional and clinical management of and research on hereditary cancer and presenting the diagnostic criteria for patients suspecting of having hereditary non-polyposis colorectal cancer (HNPCC)